Zymeworks CFO files Form 3 showing no holdings
Zymeworks Inc. executive vice president and chief financial officer Kristin Stafford filed an initial Form 3 indicating she currently has no securities beneficially owned in the company.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Zymeworks Inc. executive vice president and chief financial officer Kristin Stafford filed an initial Form 3 indicating she currently has no securities beneficially owned in the company. The filing lists both common and derivative securities as having zero shares, reflecting no direct reportable ownership as of the reported date.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
Stafford Kristin
Role
EVP, Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | No securities are beneficially owned | -- | -- | -- |
| Holding | No securities are beneficially owned | -- | -- | -- |
Holdings:
No securities are beneficially owned — 0 contracts (Direct);
No securities are beneficially owned — 0 shares (Direct)
Footnotes (1)
- F1. Not applicable.
Key Figures
Beneficial ownership: 0.0000 shares
Exercise price on derivatives: 0.0000
Holding entries: 2 entries
+1 more
4 metrics
Beneficial ownership
0.0000 shares
Total shares following reported holdings
Exercise price on derivatives
0.0000
Listed for derivative securities with no ownership
Holding entries
2 entries
Transaction summary holding records with unknown code
Net buy/sell shares
0 shares
No buys or sells reported; net direction neutral
Key Terms
beneficially owned, Form 3, derivative securities, EVP, Chief Financial Officer
4 terms
beneficially owned financial
"security_title: "No securities are beneficially owned""
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Form 3 regulatory
"INSIDER FILING DATA (Form 3)"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
derivative securities financial
"derivativeSummary entry listing "No securities are beneficially owned""
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
EVP, Chief Financial Officer financial
"officer_title: "EVP, Chief Financial Officer""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Kristin Stafford’s Form 3 for ZYME show?
The Form 3 shows that Zymeworks’ EVP and CFO, Kristin Stafford, reports no securities beneficially owned. Both common and derivative securities are listed with zero shares, meaning there is no reportable insider ownership as of the filing date.
Who is the insider named in the Zymeworks (ZYME) Form 3 filing?
The insider is Kristin Stafford, serving as EVP, Chief Financial Officer of Zymeworks Inc. The filing is her initial statement of beneficial ownership, and it reports zero directly owned common or derivative securities of the company.
Are there any derivative securities reported in Kristin Stafford’s ZYME Form 3?
The filing lists a derivative entry titled “No securities are beneficially owned” with an exercise price of 0.0000 and 0.0000 underlying shares. This confirms there are no derivative securities beneficially owned or reportable in the Form 3.
What transaction activity is disclosed in the Zymeworks (ZYME) Form 3?
The Form 3 shows no buy or sell transactions. The transaction summary indicates zero buys, zero sells, and two holding entries with an unknown code, resulting in a net neutral position and 0.0000 total shares beneficially owned.
Is the ZYME Form 3 a major event for Zymeworks investors?
This Form 3 is a routine regulatory filing showing an executive’s initial ownership status. It indicates no beneficial ownership by the CFO but does not disclose financial results, deals, or other major corporate events that would significantly change an investment thesis.
AI-generated analysis. How Rhea-AI works. Not financial advice.
